Careers Contact
Careers Contact

About us

Evaxion is a pioneering TechBio company based upon its proprietary, clinically validated and scalable AI platform, AI-Immunology™. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases.

Our purpose

Modern medicine is advancing rapidly, yet too many people still die of cancer, drug-resistant bacteria, and other infectious diseases. The demand for new, efficient drugs has never been higher and will only grow.

Every day, our AI-Immunology™ platform is bringing us closer to a future where we will be able to treat a wide range of critical diseases in a targeted, patient-specific way. We see an immense market for new, efficient, and personalized drugs, as well as a substantial way to improve patients’ quality of life.

This is why our purpose is to: Save and improve lives with AI-Immunology™.

How we do it

At Evaxion, our AI-Immunology™ platform is at the heart of our work to revolutionize drug development and ultimately save the lives of patients.

We bridge AI technology, bioinformatics, and drug development to bring novel immunotherapies to patients. We have used our AI to generate a broad pipeline of candidate immunotherapies that address two of the most significant unmet medical needs worldwide: cancer and infectious diseases.

The predictive power of our AI models comes from our ability to process and interpret vast amounts of data. These data are transformed into advanced algorithms that we believe can accurately predict cellular interactions and identify the right target to stimulate a relevant, potentially lifesaving response.

Our key facts (as of July 2026)

0

years of development

0

Initial Public Offering (IPO) on U.S. Nasdaq

0

in-house developed assets between preclinical and phase 2

0

preclinical studies

Careers

As a pioneering and leading TechBio company, we seek, employ, and develop the best scientific minds and extraordinarily skilled people. At Evaxion, you will work in a fast-paced environment that cultivates a collaborative and innovative spirit. From our cutting-edge science to our company culture, we strive for excellence in everything we do. With some of the most talented bioinformaticians, scientists, and executives in the field, we are committed to making our vision for better global health a reality. Play an instrumental role in the expansion of Evaxion and explore our open positions.

Learn more

Evaxion leadership team

Evaxion is comprised of an experienced leadership team and advisors with a proven track record from leading pharmaceutical companies and universities.
Chief Executive Officer

Helen Tayton-Martin

Chief Scientific Officer & Chief Operating Officer

Birgitte Rønø

Chief Financial Officer

Thomas Schmidt

Founder & Chief AI Officer

Andreas Mattsson

Evaxion board of directors

Evaxion is comprised of an experienced leadership team and advisors with a proven track record from leading pharmaceutical companies and universities.
Chair of the board

Marianne Søgaard

Board member

Lars Staal Wegner

Board member

Roberto Prego

Board member

Lars Holtug

Board member

Jens Bitsch-Nørhave